• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿病的早期检测

Early Detection of Huntington Disease.

作者信息

Paulsen Jane S

机构信息

University of Iowa, The Roy J. and Lucille A. Carver College of Medicine, Departments of Psychiatry, Neurology, Neurosciences, and Psychology, Iowa City, IA.

出版信息

Future Neurol. 2010 Jan;5(1). doi: 10.2217/fnl.09.78.

DOI:10.2217/fnl.09.78
PMID:24348095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3860286/
Abstract

Huntington disease (HD) is a devastating illness, although its autosomal dominant genetic transmission allows a unique opportunity to study apparently healthy individuals before manifest disease. Attempts to study early disease are not unique in neurology (e.g., Mild Cognitive Impairment, Vascular Cognitive Impairment), but studying otherwise-healthy appearing individuals who will go on with nearly 99% certainty to manifest the symptoms of brain disease does provide distinct but valuable information about the true natural history of the disease. The field has witnessed an explosion of research examining possible early indicators of HD during what is now referred to as the "prodrome" of HD. A NIH study in its ninth year (PREDICT-HD) has offered a glimpse into the transition from an apparently healthy state to an obviously diseased state, and can serve as a model for many other genetic diseases, both neurological and non-neurological.

摘要

亨廷顿舞蹈症(HD)是一种极具破坏性的疾病,尽管其常染色体显性遗传传递为在疾病显现之前研究表面健康的个体提供了独特的机会。在神经病学领域,研究早期疾病并非罕见(例如轻度认知障碍、血管性认知障碍),但研究那些几乎有99%的确定性会继续出现脑部疾病症状的表面健康个体,确实能提供有关该疾病真实自然史的独特而有价值的信息。在如今被称为HD“前驱期”的阶段,该领域见证了大量研究,旨在探究HD可能的早期指标。美国国立卫生研究院(NIH)开展了一项为期九年的研究(PREDICT-HD),让我们得以一窥从表面健康状态到明显患病状态的转变过程,并且可以作为许多其他神经和非神经遗传性疾病的研究模型。

相似文献

1
Early Detection of Huntington Disease.亨廷顿病的早期检测
Future Neurol. 2010 Jan;5(1). doi: 10.2217/fnl.09.78.
2
Biomarkers to Enable the Development of Neuroprotective Therapies for Huntington’s Disease助力亨廷顿舞蹈病神经保护疗法研发的生物标志物
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study.用于评估亨廷顿病认知和运动症状的远程数字监测平台:横断面验证研究。
J Med Internet Res. 2022 Jun 28;24(6):e32997. doi: 10.2196/32997.
5
Neuropsychological performance and disease burden in individuals at risk of developing Huntington disease.有患亨廷顿舞蹈病风险个体的神经心理表现及疾病负担
Neurologia (Engl Ed). 2024 Mar;39(2):127-134. doi: 10.1016/j.nrleng.2024.01.006. Epub 2024 Jan 23.
6
Severity of cognitive impairment in juvenile and late-onset Huntington disease.青少年型和晚发型亨廷顿病认知障碍的严重程度
Arch Neurol. 1998 Jun;55(6):835-43. doi: 10.1001/archneur.55.6.835.
7
Neuropsychological performance and disease burden in individuals at risk of developing Huntington disease.有患亨廷顿舞蹈病风险个体的神经心理学表现及疾病负担
Neurologia (Engl Ed). 2021 Jun 2. doi: 10.1016/j.nrl.2021.04.015.
8
The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.磷酸二酯酶 10 正电子发射断层扫描示踪剂 [18F]MNI-659 作为早期亨廷顿病的新型生物标志物。
JAMA Neurol. 2014 Dec;71(12):1520-8. doi: 10.1001/jamaneurol.2014.1954.
9
Huntington disease: natural history, biomarkers and prospects for therapeutics.亨廷顿病:自然史、生物标志物和治疗前景。
Nat Rev Neurol. 2014 Apr;10(4):204-16. doi: 10.1038/nrneurol.2014.24. Epub 2014 Mar 11.
10
Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study.在神经生物学预测 HD 研究(PREDICT-HD)中对前驱期亨廷顿病抑郁的特征描述。
J Psychiatr Res. 2013 Oct;47(10):1423-31. doi: 10.1016/j.jpsychires.2013.05.026. Epub 2013 Jun 19.

引用本文的文献

1
Along-Tract Diffusion Alterations in the Dentato-Rubro-Thalamic Tract Correlate With Motor and Cognitive Decline in Huntington's Disease.齿状核-红核-丘脑束的长程扩散改变与亨廷顿舞蹈病的运动和认知衰退相关。
Hum Brain Mapp. 2025 Aug 1;46(11):e70305. doi: 10.1002/hbm.70305.
2
Genomic and Transcriptomic Approaches Advance the Diagnosis and Prognosis of Neurodegenerative Diseases.基因组学和转录组学方法推动神经退行性疾病的诊断与预后研究。
Genes (Basel). 2025 Jan 24;16(2):135. doi: 10.3390/genes16020135.
3
Differential Cellular Balance of Olfactory and Vomeronasal Epithelia in a Transgenic BACHD Rat Model of Huntington's Disease.

本文引用的文献

1
Diffusion Tensor Imaging in Preclinical Huntington's Disease.临床前亨廷顿舞蹈症的扩散张量成像
Brain Imaging Behav. 2009 Mar 1;3(1):77-84. doi: 10.1007/s11682-008-9051-2.
2
Self-paced timing detects and tracks change in prodromal Huntington disease.自我调整时间检测和跟踪前驱亨廷顿病的变化。
Neuropsychology. 2010 Jul;24(4):435-42. doi: 10.1037/a0018905.
3
"Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness.亨廷顿病诊断前的“额叶”行为及其与疾病进展标志物的关系:早期缺乏意识的证据。
亨廷顿病转基因 BACHD 大鼠模型嗅上皮和犁鼻器上皮细胞的差异细胞平衡。
Int J Mol Sci. 2022 Jul 10;23(14):7625. doi: 10.3390/ijms23147625.
4
An Australian Neuro-Palliative perspective on Huntington's disease: a case report.澳大利亚神经姑息治疗视角下的亨廷顿病:病例报告。
BMC Palliat Care. 2021 Apr 1;20(1):53. doi: 10.1186/s12904-021-00744-z.
5
The Therapeutic Potential of Neuronal K-Cl Co-Transporter KCC2 in Huntington's Disease and Its Comorbidities.神经元 K-Cl 协同转运蛋白 KCC2 在亨廷顿病及其共病中的治疗潜力。
Int J Mol Sci. 2020 Nov 30;21(23):9142. doi: 10.3390/ijms21239142.
6
Classification of Huntington Disease using Acoustic and Lexical Features.利用声学和词汇特征对亨廷顿病进行分类
Interspeech. 2018;2018:1898-1902. doi: 10.21437/interspeech.2018-2029.
7
Time-varying Hazards Model for Incorporating Irregularly Measured, High-Dimensional Biomarkers.用于纳入不规则测量的高维生物标志物的时变风险模型
Stat Sin. 2020 Jul;30(3):1605-1632. doi: 10.5705/ss.202017.0375.
8
Locus of control in patients with Huntington disease: a cross-sectional study.亨廷顿病患者的控制点:一项横断面研究。
J Can Chiropr Assoc. 2020 Apr;64(1):65-75.
9
Accuracy of automated amygdala MRI segmentation approaches in Huntington's disease in the IMAGE-HD cohort.亨廷顿病 IMAGE-HD 队列中基于 MRI 的自动杏仁核分割方法的准确性。
Hum Brain Mapp. 2020 May;41(7):1875-1888. doi: 10.1002/hbm.24918. Epub 2020 Feb 7.
10
The effect of impulsivity and inhibitory control deficits in the saccadic behavior of premanifest Huntington's disease individuals.在亨廷顿病前期个体的扫视行为中,冲动和抑制控制缺陷的影响。
Orphanet J Rare Dis. 2019 Nov 8;14(1):246. doi: 10.1186/s13023-019-1218-y.
J Neuropsychiatry Clin Neurosci. 2010 Spring;22(2):196-207. doi: 10.1176/jnp.2010.22.2.196.
4
Irritability in pre-clinical Huntington's disease.亨廷顿病前临床期的易激惹。
Neuropsychologia. 2010 Jan;48(2):549-57. doi: 10.1016/j.neuropsychologia.2009.10.016. Epub 2009 Oct 28.
5
Delivering difficult news in psychiatric settings.在精神科环境中传递艰难的消息。
Harv Rev Psychiatry. 2009;17(5):315-21. doi: 10.3109/10673220903271780.
6
Randomized controlled trial of atomoxetine for cognitive dysfunction in early Huntington disease.随机对照试验研究阿托西汀治疗亨廷顿病早期认知功能障碍。
J Clin Psychopharmacol. 2009 Oct;29(5):484-7. doi: 10.1097/JCP.0b013e3181b2ac0a.
7
Progression in prediagnostic Huntington disease.亨廷顿病的预诊断进展。
J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):379-84. doi: 10.1136/jnnp.2009.176982. Epub 2009 Sep 1.
8
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.亨廷顿舞蹈病纵向TRACK-HD研究中的生物学和临床表现:基线数据的横断面分析
Lancet Neurol. 2009 Sep;8(9):791-801. doi: 10.1016/S1474-4422(09)70170-X. Epub 2009 Jul 29.
9
Therapeutic interventions for disease progression in Huntington's disease.亨廷顿舞蹈症疾病进展的治疗干预措施。
Cochrane Database Syst Rev. 2009 Jul 8;2009(3):CD006455. doi: 10.1002/14651858.CD006455.pub2.
10
Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study.亨廷顿舞蹈病临床前患者的运动异常:PREDICT-HD研究
Mov Disord. 2009 Sep 15;24(12):1763-72. doi: 10.1002/mds.22601.